Arrhythmogenic right ventricular dysplasia/cardiomyopathy

Kalpana R Prakasa1, Hugh Calkins

  • 1Carnegie 592, Johns Hopkins Hospital, 600, N. Wolfe Street, Baltimore, MD 21287, USA.

Insights

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) diagnosis relies on established criteria, not solely MRI. Early identification and ICD implantation are crucial for managing ventricular arrhythmias and preventing sudden death in ARVD/C patients.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Diagnostics

Background:

  • Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a genetic heart condition causing ventricular arrhythmias and right ventricular dysfunction.
  • Accurate diagnosis is paramount for effective ARVD/C management.
  • Current diagnostic practices may overemphasize MRI, neglecting established International Task Force criteria.

Purpose of the Study:

  • To highlight the importance of International Task Force criteria for diagnosing ARVD/C.
  • To emphasize the typical noninvasive and invasive diagnostic findings in ARVD/C.
  • To guide treatment decisions, including ICD implantation and genetic screening.

Main Methods:

  • Review of diagnostic criteria for ARVD/C.
  • Discussion of noninvasive tests (ECG, echocardiogram) and invasive tests (RV angiogram, biopsy, EP study).
  • Consideration of implantable cardioverter-defibrillator (ICD) indications and pharmacologic treatments (beta-blockers, ACE inhibitors).
  • Emphasis on genetic screening for plakophilin-2 mutations.

Main Results:

  • ARVD/C diagnosis requires adherence to International Task Force criteria.
  • Patients typically present with abnormal ECG, echocardiogram, and ventricular arrhythmias.
  • Invasive testing is recommended when noninvasive findings are suggestive.
  • ICDs are indicated for syncope, sudden death, sustained ventricular arrhythmias, or specific ARVD/C evidence.
  • Beta blockers and ACE inhibitors are recommended treatments.
  • Plakophilin-2 mutation screening is beneficial for diagnosis and family management.

Conclusions:

  • Correct diagnosis of ARVD/C hinges on International Task Force criteria.
  • A comprehensive approach combining noninvasive, invasive, and genetic testing is essential.
  • Timely ICD implantation and appropriate medical therapy improve outcomes for ARVD/C patients.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.